Bioneer Corporation

KOSDAQ 064550.KQ

Bioneer Corporation Cash and Short-Term Investments for the year ending December 31, 2023: USD 70.53 M

Bioneer Corporation Cash and Short-Term Investments is USD 70.53 M for the year ending December 31, 2023, a 11.55% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Bioneer Corporation Cash and Short-Term Investments for the year ending December 31, 2022 was USD 63.23 M, a -8.58% change year over year.
Bioneer Corporation Cash and Short-Term Investments for the year ending December 31, 2021 was USD 69.16 M, a 25.94% change year over year.
Bioneer Corporation Cash and Short-Term Investments for the year ending December 31, 2020 was USD 54.91 M, a 152.44% change year over year.
Bioneer Corporation Cash and Short-Term Investments for the year ending December 31, 2019 was USD 21.75 M, a 65.36% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

KOSDAQ: 064550.KQ

Bioneer Corporation

CEO	Han-Oh Park
IPO Date	Dec. 29, 2005
Location	South Korea
Headquarters	8-11, Munpyeongseo-ro
Employees	608
Sector	Healthcare
Industries Biotechnology Plastics

Description

Bioneer Corporation engages in the biotechnology research products, molecular diagnosis, drugs, and probiotics businesses in South Korea. The company offers PCR and RT-PCR, real-time PCR, RNAi, chemicals, plastic consumables, and buffer solutions; and sample preparation, protein synthesis and purification, gene cloning, fluorescence dye and quencher, electrophoresis, genome-wide functional analysis, and magnetic separation services, as well as instruments for conventional PCR, real-time PCR, sample preparation, protein synthesis, centrifuge and vortex mixer, electrophoresis, spectrophotometer, and microbial culture. It also provides molecular diagnosis, including MDx technologies, human diagnostics kits, MDx extraction kits, and instruments; and products for animal diseases and nano-bio products. The company was founded in 1992 and is headquartered in Daejeon, South Korea.

Key trends

Past 5 years